Abstract | BACKGROUND: METHODS: Sixty hypertensive patients who received a single-pill fixed-dose combination of valsartan 80 mg/day and amlodipine 5 mg/day were enrolled (UMIN Registration 000013460). They were randomly divided into two treatment groups [single-pill fixed-dose combination therapy with valsartan 80 mg/day and amlodipine 5 mg/day (Val/Am group), or irbesartan 100 mg/day and amlodipine 5 mg/day (Irb/Am group)] and treated for 16 weeks. If the patient did not reach the target office BP at 8 weeks, they received double doses of amlodipine (10 mg/day). RESULTS: In the Irb/Am group, systolic BP (SBP) and diastolic BP (DBP) were significantly decreased at 16 weeks. There were no significant changes in SBP or DBP in the Val/Am group. In the Irb/Am group, serum uric acid (UA) was significantly decreased at 8 weeks and patients who had hyperuricemia showed significantly decreased serum UA at 16 weeks. In addition, the levels of triglycerides (TG) were significantly decreased at 16 weeks in the Irb/Am group. CONCLUSION:
|
Authors | Kota Motozato, Shin-Ichiro Miura, Yuhei Shiga, Takaaki Kusumoto, Sen Adachi, Takeshi Inoue, Kazuaki Fujisawa, Keijiro Saku |
Journal | Clinical and experimental hypertension (New York, N.Y. : 1993)
(Clin Exp Hypertens)
Vol. 38
Issue 1
Pg. 45-50
( 2016)
ISSN: 1525-6006 [Electronic] England |
PMID | 26268636
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Antihypertensive Agents
- Biphenyl Compounds
- Drug Combinations
- Tetrazoles
- Triglycerides
- Amlodipine
- Uric Acid
- Valsartan
- Irbesartan
|
Topics |
- Aged
- Amlodipine
(administration & dosage, adverse effects)
- Antihypertensive Agents
(administration & dosage, adverse effects)
- Biphenyl Compounds
(administration & dosage, adverse effects)
- Blood Pressure
(drug effects)
- Dose-Response Relationship, Drug
- Drug Combinations
- Drug Monitoring
- Female
- Humans
- Hypertension
(blood, diagnosis, drug therapy, physiopathology)
- Irbesartan
- Male
- Middle Aged
- Tetrazoles
(administration & dosage, adverse effects)
- Treatment Outcome
- Triglycerides
(blood)
- Uric Acid
(blood)
- Valsartan
(administration & dosage, adverse effects)
|